Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Galapagos NV (PK) | GLPGF | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 26.20 | 16:22:28 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 26.20 | 26.20 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 26.20 - 41.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 26.20 | USD |
Galapagos NV (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.78B | 26.77M | - | 843.8M | 211.7M | 3.22 | 8.39 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Galapagos NV (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLPGF Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 26.20 | 26.20 | 26.20 | 26.20 | 190 | 0.00 | 0.00% |
| 3 Months | 36.20 | 36.20 | 26.20 | 35.17 | 1,677 | -10.00 | -27.62% |
| 6 Months | 33.82 | 36.21 | 26.20 | 34.50 | 2,007 | -7.62 | -22.53% |
| 1 Year | 41.60 | 41.75 | 26.20 | 36.88 | 1,295 | -15.40 | -37.02% |
| 3 Years | 75.05 | 78.74 | 26.20 | 45.82 | 9,308 | -48.85 | -65.09% |
| 5 Years | 113.25 | 276.21 | 26.20 | 108.01 | 6,400 | -87.05 | -76.87% |
Galapagos NV (PK) Description
| Galapagos is a midsized biotechnology company, with therapeutic programs based on proprietary disease modifying drug targets, and a focus on inflammation, orphan disease, and anti-infectives. Galapagos' approach is to develop drugs that stop or reverse a disease state using novel targets that are identified through a patent protected target discovery platform. Galapagos also provides access to its target and drug discovery platform through its services division, BioFocus and Argenta, which offers a full suite of target-to-drug discovery products and services to pharmaceutical and biotech companies. |
